CN Patent

CN103664802B — 作为受体酪氨酸激酶抑制剂的喹唑啉类似物

Assigned to Array Biopharma Inc · Expires 2015-08-05 · 11y expired

What this patent protects

本发明提供下式(I)表示的喹唑啉类似物：其中A与双环的5、6、7或8位碳的至少一个结合，并且其中环被最多两个独立的R 3 基团取代。本发明还包括使用式(I)所示化合物作为I型受体酪氨酸激酶抑制剂和用于治疗过度增生性疾病如癌症的方法。

USPTO Abstract

本发明提供下式(I)表示的喹唑啉类似物：其中A与双环的5、6、7或8位碳的至少一个结合，并且其中环被最多两个独立的R 3 基团取代。本发明还包括使用式(I)所示化合物作为I型受体酪氨酸激酶抑制剂和用于治疗过度增生性疾病如癌症的方法。

Drugs covered by this patent

neratinib-maleate (NERATINIB MALEATE)

Patent Metadata

Patent number: CN103664802B
Jurisdiction: CN
Classification: —
Expires: 2015-08-05
Drug substance claim: No
Drug product claim: No
Assignee: Array Biopharma Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.